Universities innovate, Big Pharma develops: Public and philanthropic funding crucial to treat cancer

On World Cancer Day, François Picard interviews Lars Henning Milman Engelholm, a leading researcher at the Finsen Laboratory in Copenhagen, who highlights significant advancements in pancreatic cancer research driven by a decade of translational science efforts.

This progress underscores the importance of public and philanthropic funding in cancer treatment, showcasing how collaborative efforts between universities and pharmaceutical companies can lead to innovative solutions and improved patient outcomes in the fight against cancer.